<?xml version="1.0" encoding="UTF-8"?>
<p id="p0205">Plasma therapy in COVID-19 patients shown safe, clinically effective, and reduces mortality based on the limited scientific data. In this simple method, doctors isolate antibodies from the plasma of recovered patientsâ€™ blood and administer them to currently exposed and infected patients. Antibodies aid in the recognition of the pathogens and reject the pathogen in the patients [
 <xref rid="bb0275" ref-type="bibr">55</xref>]. However, large multicenter clinical trials are urgently needed to conclude the optimal doses and treatment time point for the CP therapy to tackle COVID-19 pandemic.
</p>
